The top story this issue (45; May 2017) reviews whether iFR, following the results of DEFINE-FLAIR and SWEDEHEART, is set to become the new standard of physiological assessment. Additionally, we report on SURTAVI, the two-year results of ABSORB III, and on the DECISION-CTO study. Furthermore, we profile Vinayak Bapat
[pdfviewer width=”100%” height=”940px” beta=”true”]https://cardiovascularnews.com/wp-content/uploads/sites/14/2017/05/CN-issue-45-US.pdf[/pdfviewer]
